News
March 28, 2019

Boston Globe Highlights Eskenazi Health, Regenstrief Researcher in Article about New Program at Massachusetts General Hospital

The Boston Globe featured an Eskenazi Health program led by Regenstrief Research Scientist Malaz Boustani, M.D., in an article describing the launch of a new Massachusetts General Hospital program to support primary care physicians in caring for older patients living with dementia.

The program is similar to the one at Sandra Eskenazi Center for Brain Care Innovation, led by Dr. Boustani, who is also the director for the Center for Health Innovation and Implementation Science.

The collaborative dementia care program was started by Eskenazi more than a decade ago. The system trains and employs community health workers who meet with families of people with dementia. The workers help those families address difficulties, actively work to reduce stress and keep track of how the families are functioning.

Massachusetts General Hospital is launching a pilot program where a dementia care team will be embedded in primary care practices at the hospital. The specialists and social workers can help those doctors when they suspect one of their patients may have dementia.

A recent survey by the Alzheimer’s Association® found that less than half of physicians reported assessing their older patients for cognitive impairment.

“I feel their pain. The primary care doctors, they don’t have the resources, they don’t have the time,” Dr. Boustani told the Globe. He believes that programs like the one at Eskenazi can lead to better health and quality of life for people with dementia and their families.

Dr. Boustani also is a professor at Indiana University School of Medicine and the director for the Center for Health Innovation and Implementation Science.

Read the entire Boston Globe Article here.

  • Dr. Malaz Boustani

Related News

LOINC version 2.81 release

Arabic and Czech translations, more than 4,000 new concepts boost global interoperability in latest LOINC® release

Regenstrief Institute’s latest LOINC® content update on August 12, introduces two new linguistic variants: Arabic, for users in Jordan,

Regenstrief President and CEO Rachel Patzer, PhD, MPH.

Regenstrief CEO among national honorees for ground-breaking achievements in transplantation

SAN FRANCISCO – Regenstrief Institute President and Chief Executive Officer Rachel Patzer, PhD, MPH, is among a select group

LOINC 2025 Conference - Montreal, Canada

Regenstrief to host 2025 LOINC® conference in Montréal, Canada, Oct. 7-10

First LOINC conference in Canada — home to one of LOINC’s largest user bases  Regenstrief Institute Health Data Standards

Katie Ross-Driscoll, PhD

Regenstrief researcher receives Showalter award to improve access to organ transplants using learning health systems approach

Regenstrief Institute Research Scientist Katie Ross-Driscoll, PhD, MPH, has been awarded a 2025 Ralph W. and Grace M. Showalter